The objective of this study was to meticulously examine the diverse vocal rehabilitation techniques that are employed following total laryngectomy, with emphasis on their implications on patients’ quality of life and on the determinants influencing the selection of one technique over another. We embarked on a comprehensive literature review, which concentrated on three primary rehabilitation approaches: tracheoesophageal puncture (TEP) accompanied by a vocal prosthesis, esophageal speech acquisition, and electrolarynx utilization. The outcomes assessed included quality of life, functional performance, communication effectiveness, patient satisfaction, and factors governing the choice of technique, such as patient demographics, disease stage, and treatment history. Our findings demonstrated that TEP with vocal prosthesis yielded the most favorable overall quality of life and patient satisfaction. Individuals who underwent TEP exhibited superior speech intelligibility, voice quality, and communication ease compared with those who employed esophageal speech acquisition or electrolarynx utilization. While esophageal speech learning exhibited inferior speech quality and functional performance, it offered cost-effectiveness and diminished maintenance advantages. Electrolarynx utilization emerged as the least preferred approach due to suboptimal speech intelligibility and voice quality. The determinants influencing the choice of vocal rehabilitation technique included patient age, sex, disease stage, and previous treatment history. Patient preferences also substantially contributed to the selection of a specific technique. It is essential for clinicians to consider individual factors and patient inclinations when deliberating on an appropriate vocal rehabilitation method following total laryngectomy. Our investigation underscores the significance of collaborative decision making between clinicians and patients to pinpoint the most fitting rehabilitation technique. Future research endeavors should be directed towards enhancing existing approaches, devising innovative methods, and probing long-term outcomes and cost-effectiveness to optimize patient care in the aftermath of total laryngectomy.
Vocal fold scarring and presbylarynx significantly impair voice quality, leading to a decline in patients' quality of life. These pathologies represent considerable challenges for laryngologists. Traditional treatments often produce suboptimal outcomes. Platelet-rich plasma (PRP) is an innovative, minimally invasive treatment that uses autologous biological material rich in growth factors and platelets, with positive effects on tissue regeneration and repair. Based on its promising effects, we started using PRP as a therapeutic option in vocal folds scars and presbylarynx. We performed a retrospective study on the efficacy and clinical outcomes of PRP injections performed in these patients. Between October 2021 and November 2023, 48 patients (35 women, 13 men; mean age 53 ± 15 years) were treated with PRP for a total of 109 injections for acute or chronic vocal fold lesions or presbylaryngis. PRP preparation followed a standardized protocol. The mean volume of PRP injected per vocal fold was 0.57 ± 0.30 mL, with high platelet purity (95.05% ± 3.48) found in PRP biological characterization. No adverse events were reported. The vocal outcomes assessed 1 month after the treatment found no modification in the acoustic parameters, but a significant improvement in the perceptual voice analysis on the G (P < 0.001), R (P = 0.005), and B (P = 0.008) of the GRB scale, and a clinical improvement on videolaryngostroboscopy for 62.5% of the patients. Most importantly, 70.8% of the patients reported subjective improvement with an average reduction in VHI-30 score of 10.79 points, with 32% of patients achieving clinically significant improvement (≥18 points). PRP injections demonstrate promising efficacy and safety in vocal fold scars and presbylaryngis treatment, with a significant improvement in perceptual voice analysis and subjective assessments. Further studies with larger cohorts and control groups are needed to confirm these findings and optimize PRP therapy protocols.